Search Results - "Simonelli, Matteo"

Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study.

Authors: Caccese, Mario Simonelli, Matteo Villani, Veronica et al.

Source: Cancers. May2022, Vol. 14 Issue 10, p2425-N.PAG. 13p.

Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.

Authors: Muglia, Riccardo Simonelli, Matteo Pessina, Federico et al.

Source: European Radiology. Jun2021, Vol. 31 Issue 6, p4079-4086. 8p. 1 Black and White Photograph, 1 Chart, 2 Graphs.

Subjects: Glioblastoma multiforme, Sarcopenia, Overall survival, Biomarkers, Prognosis, Brain tumors

Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.

Authors: Lorenzi, Elena Simonelli, Matteo Santoro, Armando

Source: Critical Reviews in Oncology/Hematology. Nov2016, Vol. 107, p1-13. 13p.

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

Authors: Simonelli, Matteo Zucali, Paolo A. Lorenzi, Elena et al.

Source: European Journal of Cancer. Mar2013, Vol. 49 Issue 5, p989-998. 10p.

Exploring the Role of ADCs in Brain Metastases and Primary Brain Tumors: Insight and Future Directions.

Authors: Bruzzone, Francesco Barigazzi, Chiara Di Muzio, Antonio et al.

Source: Cancers. May2025, Vol. 17 Issue 9, p1591. 37p.

Proliferation-Diffusion Modeling in Glioblastoma: Impact of Supramaximal Resection on Survival.

Authors: Tropeano, Maria Pia Rossini, Zefferino Bresciani, Ettore et al.

Source: Cancers. Mar2025, Vol. 17 Issue 6, p995. 12p.

Tumor boundary delineation in IDH-wildtype glioblastoma: A prospective comparative analysis of ¹¹C-MET PET and FLAIR MRI in surgical decision-making.

Authors: Tropeano, Maria Pia Rossini, Zefferino Pizzi, Andrea et al.

Source: Neuro-Oncology Practice. Aug2026, Vol. 13 Issue 4, p767-774. 8p.

Biomarker and pharmacodynamic activity of the transforming growth factor‐beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors.

Authors: Robbrecht, Debbie Grob, Jean‐Jacques Bechter, Oliver et al.

Source: CTS: Clinical & Translational Science. Feb2024, Vol. 17 Issue 2, p1-11. 11p.

T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression.

Authors: Losurdo, Agnese Di Muzio, Antonio Cianciotti, Beatrice Claudia et al.

Source: Cancers. Feb2024, Vol. 16 Issue 3, p603. 29p.

Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?

Authors: Simonelli, Matteo Dipasquale, Angelo Orzan, Francesca et al.

Source: Critical Reviews in Oncology/Hematology. Feb2020, Vol. 146, pN.PAG-N.PAG. 1p.

Role of myeloid cells in the immunosuppressive microenvironment in gliomas.

Authors: Locarno, Chiara V. Simonelli, Matteo Carenza, Claudia et al.

Source: Immunobiology. Jan2020, Vol. 225 Issue 1, pN.PAG-N.PAG. 1p.

Case study: Successful full-course chemotherapy administration in a liver transplant recipient diagnosed with central nervous system World Health Organization Grade 2 IDH mutant/1p-19q co-deleted oligodendroglioma.

Authors: Dipasquale, Angelo Losurdo, Agnese Persico, Pasquale et al.

Source: Neuro-Oncology Practice. Oct2025, Vol. 12 Issue 5, p922-927. 6p.

Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort.

Authors: Rha, Sun Young Castanon, Eduardo Gill, Sanjeev et al.

Source: Cancer (0008543X). Aug2025, Vol. 131 Issue 16, p1-12. 12p.

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study.

Authors: Caccese, Mario Ius, Tamara Simonelli, Matteo et al.

Source: International Journal of Molecular Sciences. Sep2020, Vol. 21 Issue 18, p6716-6716. 1p.

COVID‐19 and liver cancer clinical trials: Not everything is lost.

Authors: D'Alessio, Antonio Personeni, Nicola Pressiani, Tiziana et al.

Source: Liver International. Jul2020, Vol. 40 Issue 7, p1541-1544. 4p. 1 Diagram.

Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.

Authors: Tropeano, Maria Pia Raspagliesi, Luca Bono, Beatrice Claudia et al.

Source: Acta Neurochirurgica. 4/27/2024, Vol. 166 Issue 1, p1-9. 9p.

Prognostic and predictive role of [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

Authors: Zucali, Paolo Andrea Lopci, Egesta Ceresoli, Giovanni Luca et al.

Source: Cancer Medicine. Oct2017, Vol. 6 Issue 10, p2287-2296. 10p.

Primary mismatch repair deficiency and Lynch syndrome in adult diffuse gliomas: A call to action.

Authors: Persico, Pasquale Dipasquale, Angelo Losurdo, Agnese et al.

Source: Cancer (0008543X). Aug2025, Vol. 131 Issue 16, p1-2. 2p.

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

Authors: Lopci, Egesta Riva, Marco Olivari, Laura et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2017, Vol. 44 Issue 7, p1155-1164. 10p. 1 Black and White Photograph, 2 Charts, 3 Graphs.

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

Authors: Scorsetti, Marta Navarria, Pierina Pessina, Federico et al.

Source: BMC Cancer. 2015, Vol. 15 Issue 1, p1-7. 7p. 4 Charts, 2 Graphs.